BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37636267)

  • 1. Prognostic effect of lncRNA BBOX1-AS1 in malignancies: a meta-analysis.
    Lin G; Wang Y; Deng L; Ye T
    Front Genet; 2023; 14():1234040. PubMed ID: 37636267
    [No Abstract]   [Full Text] [Related]  

  • 2. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
    Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
    BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between long non-coding RNA MAFG-AS1 and cancer prognosis: a meta-analysis.
    Lin G; Liu H; Lin J; Liu X; Xu L
    Front Oncol; 2023; 13():1286610. PubMed ID: 38130989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets.
    Shu Q; Liu X; Yang J; Mou T; Xie F
    Medicine (Baltimore); 2022 Oct; 101(42):e31439. PubMed ID: 36281152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of long noncoding RNA TTN-AS1 in various malignancies.
    Lin G; Liu X; Cong C; Xu L
    Cancer Rep (Hoboken); 2023 Oct; 6(10):e1876. PubMed ID: 37528740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway.
    Shi J; Yang C; An J; Hao D; Liu C; Liu J; Sun J; Jiang J
    J Exp Clin Cancer Res; 2021 Apr; 40(1):148. PubMed ID: 33931086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles.
    Zhang Y; Liang C; Zhang Y; Wang Z; Li R; Wei Z; Guo J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
    Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
    Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
    Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
    Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.
    Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L
    Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA BBOX1-AS1 Contributes to the Development of Nasopharyngeal Carcinoma via miR-204-5p/MUC4 Axis.
    Xiong J; Zhou L; Zhou Y
    Ann Clin Lab Sci; 2023 May; 53(3):366-379. PubMed ID: 37437933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA BBOX1-AS1 Contributes to the Progression of Esophageal Carcinoma by Targeting the miR-361-3p/COL5A1 Axis.
    Lu YH; He DS; Li Y; Wang H; Ma RD
    Biochem Genet; 2023 Aug; 61(4):1351-1368. PubMed ID: 36586008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA BBOX1-AS1 Aggravates the Development of Ovarian Cancer by Sequestering miR-361-3p to Augment PODXL Expression.
    Yao H; Chen R; Yang Y; Jiang J
    Reprod Sci; 2021 Mar; 28(3):736-744. PubMed ID: 33159291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA ZEB1-AS1 expression in cancer prognosis: Review and meta-analysis.
    Chen C; Feng Y; Wang X
    Clin Chim Acta; 2018 Sep; 484():265-271. PubMed ID: 29885321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a ceRNA Network and a Prognostic lncRNA Signature associated with Vascular Invasion in Hepatocellular Carcinoma based on Weighted Gene Co-Expression Network Analysis.
    Tao H; Li J; Liu J; Yuan T; Zhang E; Liang H; Huang Z
    J Cancer; 2021; 12(13):3754-3768. PubMed ID: 34093785
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic and clinical significance of long non-coding RNA HNF1A-AS1 in solid cancers: A systematic review and meta-analysis.
    Zhou X; Fan YH; Wang Y; Liu Y
    Medicine (Baltimore); 2019 Dec; 98(49):e18264. PubMed ID: 31804362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA BBOX1-AS1 silencing inhibits esophageal squamous cell cancer progression by promoting ferroptosis via miR-513a-3p/SLC7A11 axis.
    Pan C; Chen G; Zhao X; Xu X; Liu J
    Eur J Pharmacol; 2022 Nov; 934():175317. PubMed ID: 36216119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance and effect of lncRNA BBOX1-AS1 on the proliferation and migration of lung squamous cell carcinoma.
    Zhang Y; Wang X; Cheng XK; Zong YY; He RQ; Chen G; Qin YJ
    Oncol Lett; 2022 Jan; 23(1):17. PubMed ID: 34820016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA NR2F1-AS1 as a potential biomarker for prognosis in cancer patients: meta and bioinformatics analysis.
    Tang L; Liu QM; Zhang S; Zhou J
    Expert Rev Mol Diagn; 2023; 23(12):1263-1272. PubMed ID: 37902251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.